Cite
Drug-induced eosinophilic fasciitis: A dual pharmacovigilance analysis.
MLA
Teboul, Alexandre, et al. “Drug-Induced Eosinophilic Fasciitis: A Dual Pharmacovigilance Analysis.” Journal of the American Academy of Dermatology, vol. 86, no. 6, June 2022, pp. 1372–75. EBSCOhost, https://doi.org/10.1016/j.jaad.2021.05.030.
APA
Teboul, A., Chouchana, L., Durrieu, G., Eftekhari, P., Treluyer, J.-M., Mouthon, L., & Chaigne, B. (2022). Drug-induced eosinophilic fasciitis: A dual pharmacovigilance analysis. Journal of the American Academy of Dermatology, 86(6), 1372–1375. https://doi.org/10.1016/j.jaad.2021.05.030
Chicago
Teboul, Alexandre, Laurent Chouchana, Geneviève Durrieu, Pirayeh Eftekhari, Jean-Marc Treluyer, Luc Mouthon, and Benjamin Chaigne. 2022. “Drug-Induced Eosinophilic Fasciitis: A Dual Pharmacovigilance Analysis.” Journal of the American Academy of Dermatology 86 (6): 1372–75. doi:10.1016/j.jaad.2021.05.030.